Prediction of nonresponsiveness to medium-dose intravenous immunoglobulin (1 g/kg) treatment: an effective and safe schedule of acute treatment for Kawasaki disease
PurposeMedium-dose (1 g/kg) intravenous immunoglobulin (IVIG) is effective in the majority of patients with Kawasaki disease (KD) but some patients who do not respond to medium-dose IVIG are at high risk for the development of coronary artery lesions (CALs). The purpose of this study was to identify...
Main Authors: | Kyung Pil Moon, Beom Joon Kim, Kyu Jin Lee, Jin Hee Oh, Ji Whan Han, Kyung Yil Lee, Soon Ju Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Pediatric Society
2016-04-01
|
Series: | Korean Journal of Pediatrics |
Subjects: | |
Online Access: | http://kjp.or.kr/upload/pdf/kjped-59-178.pdf |
Similar Items
-
Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
by: Hyo Min Park, et al.
Published: (2013-02-01) -
Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
by: Hun-Ju Yu, et al.
Published: (2021-03-01) -
Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
by: Min Seob Song
Published: (2019-04-01) -
Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease
by: Matsuura Hiroyuki, et al.
Published: (2011-09-01) -
Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
by: Yaheng Lu, et al.
Published: (2021-09-01)